Spark Biomedical creates a subsidiary, Five Liters, to focus the initiative while taking advantage of the company’s experience in turning patents into FDA-approved products.
The companies partnered to design, develop and manufacture the medical device technology that provides a wearable neurostimulation solution for opioid withdrawal relief
The jointly run pilot clinical study is the first step in pioneering closed-loop opioid withdrawal detection and treatment
